Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons

INTRODUCTION: Biologic disease-modifying anti-rheumatic drugs (bDMARDs), including certolizumab pegol (CZP), are effective treatment options for the management of non-radiographic spondyloarthritis (nr-axSpA). In the absence of head-to-head comparisons in nr-axSpA, we conducted a systematic literatu...

Descripción completa

Detalles Bibliográficos
Autores principales: Akkoç, Nurullah, Arteaga, Carlos H., Auteri, Simone E., Betts, Marissa, Fahrbach, Kyle, Kim, Mindy, Kiri, Sandeep, Neupane, Binod, Gaffney, Karl, Mease, Philip J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011375/
https://www.ncbi.nlm.nih.gov/pubmed/36633815
http://dx.doi.org/10.1007/s40744-022-00522-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011375/
https://www.ncbi.nlm.nih.gov/pubmed/36633815
http://dx.doi.org/10.1007/s40744-022-00522-0

Ejemplares similares